Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization [Phase 4]
Phase 4 clinical trial update evaluating the benefit of the transradial approach for cardiac catheterization in patients with chronic kidney…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: KidneYou - Innovative Digital Therapy [NA]
Completed clinical trial update for KidneYou, an innovative digital therapy from Advice Pharma Group srl, investigating use in chronic kidne…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis [Phase 1]
Phase 1 clinical trial update evaluating pharmacokinetics and safety of ASP7991 in chronic kidney disease patients on hemodialysis.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan [Phase 1]
Astellas-sponsored Phase 1 single- and multiple-dose study in Japanese patients with hyperphosphatemia undergoing hemodialysis (in the conte…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction [Phase 1]
A Phase 1 trial of PF-07081532 in people with type 2 diabetes mellitus and chronic kidney disease was terminated; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Determining the Effect of Individualized Education Program in Kidney Transplant Patients [NA]
A completed clinical trial evaluating the effect of an individualized education program in kidney transplant patients.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Resveratrol and Vascular Function in CKD [NA]
A completed clinical trial evaluated the effect of resveratrol on vascular function in individuals with chronic kidney disease and endotheli…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia [Phase 3]
Astellas reports completion of a Phase 3 study evaluating intermittent oral dosing of ASP1517 in non-dialysis chronic kidney disease patient…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease [Phase 2]
A Phase 2 study evaluating ASP8232 as add-on therapy to ACE inhibitors or ARBs to reduce albuminuria in patients with type 2 diabetes and ch…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia [Phase 3]
Phase 3 trial of intermittent oral dosing of ASP1517 in ESA-untreated chronic kidney disease patients with anemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register
This completed observational trial from Astellas Pharma Europe Ltd. evaluated the epidemiology of anemia in patients with chronic kidney dis…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Effect of a Concurrent Physical Exercise Program in Hemodialysis Patients [NA]
A completed clinical trial evaluated the effect of a concurrent physical exercise program in patients undergoing hemodialysis for chronic ki…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment [Phase 3]
This document reports the completion of a Phase 3 long-term trial of intermittent oral ASP1517 in hemodialysis patients with anemia due to c…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug [Phase 2]
This update summarizes the completion of a Phase 2 trial evaluating ASP1517 versus darbepoetin in dialysis-dependent chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia [Phase 3]
Phase 3 trial evaluating intermittent oral dosing of ASP1517 in ESA-naive hemodialysis patients with anemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia [Phase 3]
Phase 3 trial evaluating intermittent oral dosing of ASP1517 in patients with chronic kidney disease undergoing peritoneal dialysis and anem…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis [Phase 1]
Phase 1 pharmacokinetics study of ASP1517 in anemia patients on hemodialysis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia [Phase 3]
Phase 3 clinical trial update on intermittent oral dosing of ASP1517 in patients with chronic kidney disease on hemodialysis and anemia; stu…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Hemofilter Life Span, ECLS And/or CRRT
Completed clinical trial update examining hemofilter lifespan during extracorporeal life support (ECLS) and/or continuous renal replacement …
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Predictive Tools for the Presence of Significant Coronary Artery Disease Requiring Intervention in Chronic Hemodialysis Patients
This clinical trial update reports the completion of a study evaluating predictive tools for identifying significant coronary artery disease…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
Post-marketing surveillance study evaluating long-term safety and real-world use of bixalomer (Kiklin) capsules for hyperphosphatemia in pat…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People [Phase 1]
This Phase 1 trial update reports completion of a study evaluating ASP0367 in adults with kidney impairment and in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
The FIRST-2.0 observational study evaluating finerenone for safety and effectiveness in real-world patients with chronic kidney disease and …
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease
Post-marketing surveillance study of Bixalomer in pre-dialysis chronic kidney disease patients has been completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Theranova Randomized, Controlled, Trial (RCT) in China [NA]
A randomized controlled trial evaluating Theranova in China has completed, and the results were posted on 2024-10-15. The sponsor listed is …